Lithium Citrate
FDA-approved product (syrup, oral), marketed as Lithium Citrate, Lithonate, Potassium Citrate and 1 more.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Anemia (phenotype)
- Bipolar I disorder
- Major depressive disorder
- Renal tubular acidosis
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Potassium; Salt solutions
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Lithium Citrate, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA11.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli14.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae10.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis27.5% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Lithium Citrate with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Ozanimod HydrochlorideExisting use: Multiple sclerosis, Relapsing-remitting multiple sclerosis, Ulcerative colitis66.8% AI-predicted activityagainst MRSA7 registered studies
- Micafungin SodiumExisting use: Candidiasis66.8% AI-predicted activityagainst MRSA50+ registered studies
- AbemaciclibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 3 more66.4% AI-predicted activityagainst MRSA50+ registered studies
- RisperidoneExisting use: Aggressive behavior, Autism, Bipolar disorder and 4 more66.4% AI-predicted activityagainst MRSA50+ registered studies
- Lazertinib MesylateExisting use: Non-small cell lung carcinoma66.1% AI-predicted activityagainst MRSANo documented evidence found
- Desmopressin AcetateExisting use: Central diabetes insipidus, Diabetes insipidus, Enuresis and 5 more65.8% AI-predicted activityagainst MRSA50+ registered studies
- Terazosin HydrochlorideExisting use: Benign prostatic hyperplasia65.8% AI-predicted activityagainst MRSA41 registered studies
- VemurafenibExisting use: Cancer, Cutaneous melanoma, Melanoma and 2 more65.8% AI-predicted activityagainst MRSA50+ registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more65.5% AI-predicted activityagainst MRSA50+ registered studies
- VenetoclaxExisting use: Cancer, Chronic lymphocytic leukemia, Neoplasm65.5% AI-predicted activityagainst MRSA50+ registered studies
- Larotrectinib SulfateExisting use: Abdominal Neoplasms, Cancer, Metastasis and 1 more65.4% AI-predicted activityagainst MRSA5 registered studies
- SirolimusExisting use: Adenoma sebaceum, Angiofibroma, Cancer and 5 more65.2% AI-predicted activityagainst MRSA50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
NCT01467700 · start 2011-12
Registered record
- Registry ID
- NCT01467700
- Conditions
- Acute Depressive Episode
- Interventions
- Ramelteon SL; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Terminated
- Start
- 2011-12
- Completion
- 2015-03
- Enrolment
- 490
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Depressive EpisodeInterventionRamelteon SL; PlaceboPhasePhase 3Registry statusTerminatedWake Therapy in the Treatment of Depression
NCT01431573 · start 2011-07
Registered record
- Registry ID
- NCT01431573
- Conditions
- Major Depressive Disorder; Bipolar Disorder
- Interventions
- Wake Therapy; light box; Lithium
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-07
- Completion
- 2016-08
- Enrolment
- 8
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMajor Depressive Disorder; Bipolar DisorderInterventionWake Therapy; light box; LithiumPhaseNot applicableRegistry statusCompletedOvernight Use of Electroacustimulation on Postoperative Nausea and Vomiting in the Outpatient Surgery Population
NCT01394536 · start 2011-06
Registered record
- Registry ID
- NCT01394536
- Conditions
- Post-operative Nausea and Vomiting
- Interventions
- Battery-operated electroacustimulation device (Inactive); Battery-operated electroacustimulation device (Active)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Withdrawn
- Start
- 2011-06
- Completion
- Not recorded
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPost-operative Nausea and VomitingInterventionBattery-operated electroacustimulation device (Inactive); Battery-operated electroacustimulation device (Active)PhaseNot applicableRegistry statusWithdrawnA Pilot Study of Lithium in Progressive Multiple Sclerosis
NCT01259388 · start 2011-05
Registered record
- Registry ID
- NCT01259388
- Conditions
- Multiple Sclerosis
- Interventions
- Lithium Carbonate
- Study type
- INTERVENTIONAL
- Phase
- Phase 1 / Phase 2
- Registry status
- Completed
- Start
- 2011-05
- Completion
- 2015-12
- Enrolment
- 23
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMultiple SclerosisInterventionLithium CarbonatePhasePhase 1 / Phase 2Registry statusCompletedDecision-Making in Bipolar Disorder
NCT01463111 · start 2011-05
Registered record
- Registry ID
- NCT01463111
- Conditions
- Bipolar Disorder
- Interventions
- Lithium; Valproate; Lamotrigine
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-05
- Completion
- 2016-04
- Enrolment
- 37
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBipolar DisorderInterventionLithium; Valproate; LamotriginePhaseNot applicableRegistry statusCompletedLithia Water Study: Effects of Lithia Water on BDNF and Oxidative Stress Markers in Healthy Male Participants
NCT01257867 · start 2011-03
Registered record
- Registry ID
- NCT01257867
- Conditions
- Oxidative Stress
- Interventions
- Lithia water; Natural spring water with negligible lithium levels
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2011-03
- Completion
- 2012-10
- Enrolment
- 5
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOxidative StressInterventionLithia water; Natural spring water with negligible lithium levelsPhaseNot applicableRegistry statusTerminatedLithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study
NCT01754883 · start 2011-01
Registered record
- Registry ID
- NCT01754883
- Conditions
- Combat Posttraumatic Stess Disorder; Mild Traumatic Brain Injury
- Interventions
- Lithium Carbonate
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Withdrawn
- Start
- 2011-01
- Completion
- 2014-01
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCombat Posttraumatic Stess Disorder; Mild Traumatic Brain InjuryInterventionLithium CarbonatePhasePhase 1Registry statusWithdrawnColorectal Cancer Detection by Means of Optical Fluoroscopy
NCT01286064 · start 2010-10
Registered record
- Registry ID
- NCT01286064
- Conditions
- Colorectal Cancer
- Interventions
- Optical Fluoroscopy; Optical Fluoroscopy
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2010-10
- Completion
- 2011-04
- Enrolment
- 200
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionColorectal CancerInterventionOptical Fluoroscopy; Optical FluoroscopyPhaseNot applicableRegistry statusUnknownEffect of Furosemide on Obesity-induced Glomerular Hyperfiltration
NCT00962286 · start 2009-09
Registered record
- Registry ID
- NCT00962286
- Conditions
- Obesity-induced Hyperfiltration
- Interventions
- Furosemide
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2009-09
- Completion
- 2010-07
- Enrolment
- 3
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionObesity-induced HyperfiltrationInterventionFurosemidePhaseNot applicableRegistry statusTerminatedThe Early Medication Change (EMC) Trial
NCT00974155 · start 2009-09
Registered record
- Registry ID
- NCT00974155
- Conditions
- Depression
- Interventions
- Escitalopram, venlafaxine, lithium; Escitalopram, venlafaxine
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2009-09
- Completion
- 2014-05
- Enrolment
- 889
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDepressionInterventionEscitalopram, venlafaxine, lithium; Escitalopram, venlafaxinePhasePhase 4Registry statusCompletedA Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)
NCT00790582 · start 2008-05
Registered record
- Registry ID
- NCT00790582
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- lithium carbonate
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2008-05
- Completion
- 2010-03
- Enrolment
- 109
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAmyotrophic Lateral SclerosisInterventionlithium carbonatePhasePhase 2Registry statusCompletedJuvenile Bipolar Disorder Outpatient Program
NCT01000402 · start 2008-02
Registered record
- Registry ID
- NCT01000402
- Conditions
- Bipolar Disorder; Attention Deficit Disorder With Hyperactivity
- Interventions
- Psychopharmacotherapy
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2008-02
- Completion
- 2014-11
- Enrolment
- 150
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBipolar Disorder; Attention Deficit Disorder With HyperactivityInterventionPsychopharmacotherapyPhasePhase 4Registry statusUnknownSafety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury
NCT00431171 · start 2007-09
Registered record
- Registry ID
- NCT00431171
- Conditions
- Spinal Cord Injuries
- Interventions
- Lithium carbonate
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2007-09
- Completion
- 2010-01
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSpinal Cord InjuriesInterventionLithium carbonatePhasePhase 1Registry statusCompletedSafety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder
NCT01075126 · start 2006-12
Registered record
- Registry ID
- NCT01075126
- Conditions
- Bipolar Disorder
- Interventions
- Depakote; Lithium
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Withdrawn
- Start
- 2006-12
- Completion
- 2006-12
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBipolar DisorderInterventionDepakote; LithiumPhasePhase 4Registry statusWithdrawnPh I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases
NCT00469937 · start 2006-02
Registered record
- Registry ID
- NCT00469937
- Conditions
- Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Neurotoxicity; Solid Tumor
- Interventions
- lithium carbonate; cognitive assessment; quality-of-life assessment; radiation therapy
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Terminated
- Start
- 2006-02
- Completion
- 2009-03
- Enrolment
- 9
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBrain and Central Nervous System Tumors; Cognitive/Functional Effects; Neurotoxicity; Solid TumorInterventionlithium carbonate; cognitive assessment; quality-of-life assessment; radiation therapyPhasePhase 1Registry statusTerminated